Mednax Inc Stock Today

MD Stock  USD 10.03  0.04  0.40%   

Performance

4 of 100

 
Low
 
High
Insignificant

Odds Of Distress

Less than 32

 
100  
 
Zero
Below Average
Mednax is trading at 10.03 as of the 28th of March 2024, a 0.40 percent increase since the beginning of the trading day. The stock's lowest day price was 9.97. Mednax has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Mednax Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of April 2023 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
19th of September 1995
Category
Healthcare
Classification
Health Care
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida. The company has 84.12 M outstanding shares of which 3.22 M shares are now sold short in the market by investors with about 4.73 days to cover all shorted shares. More on Mednax Inc

Moving against Mednax Stock

  0.58LNSR LENSAR IncPairCorr
  0.54EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.47RNLX Renalytix AI Report 4th of April 2024 PairCorr

Mednax Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mednax's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mednax or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Mednax's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mednax's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEO DirectorJames MD
Thematic IdeaHealthcare (View all Themes)
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP Small-Cap 600, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors)
Average Analyst Recommendation
Analysts covering Mednax report their recommendations after researching Mednax's financial statements, talking to executives and customers, or listening in on Mednax's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Mednax Inc. The Mednax consensus assessment is calculated by taking the average forecast from all of the analysts covering Mednax.
Financial Strength
Based on the key measurements obtained from Mednax's financial statements, Mednax Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. Financial strength of Mednax Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.790.8986
Fairly Down
Pretty Stable
Gross Profit Margin0.20.2113
Notably Down
Slightly volatile
Total Current Liabilities284.3 M388.9 M
Way Down
Slightly volatile
Non Current Liabilities Total731 M981.8 M
Way Down
Slightly volatile
Total Assets2.2 B2.2 B
Slightly Up
Very volatile
Total Current Assets382.4 M483.5 M
Significantly Down
Slightly volatile
Total Cash From Operating Activities210.1 M137.3 M
Way Up
Pretty Stable
Mednax's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Mednax's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Mednax's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Mednax's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mednax's financial leverage. It provides some insight into what part of Mednax's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Mednax's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Mednax deploys its capital and how much of that capital is borrowed.
Liquidity
Mednax cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company reports 701.65 M of total liabilities with total debt to equity ratio (D/E) of 1.03, which is normal for its line of buisiness. Mednax Inc has a current ratio of 1.36, which is generally considered normal. Debt can assist Mednax until it has trouble settling it off, either with new capital or with free cash flow. So, Mednax's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mednax Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mednax to invest in growth at high rates of return. When we think about Mednax's use of debt, we should always consider it together with cash and equity.

Change In Cash

66.61 Million
Mednax Inc (MD) is traded on New York Stock Exchange in USA. It is located in 1301 Concord Terrace, Sunrise, FL, United States, 33323 and employs 5,450 people. Mednax is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a market capitalization of 806.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mednax's market, we take the total number of its shares issued and multiply it by Mednax's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mednax Inc is active under Health Care Providers & Services sector as part of Health Care industry. The entity has 84.12 M outstanding shares of which 3.22 M shares are now sold short in the market by investors with about 4.73 days to cover all shorted shares. Mednax Inc reports about 9.82 M in cash with 137.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.29.
Check Mednax Probability Of Bankruptcy
Ownership Allocation
Mednax Inc holds a total of 84.12 Million outstanding shares. The majority of Mednax outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Mednax Inc to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Mednax Inc. Please pay attention to any change in the institutional holdings of Mednax as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Mednax Ownership Details

Mednax Stock Price Odds Analysis

What are Mednax's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Mednax jumping above the current price in 90 days from now is roughly 2.28%. The Mednax Inc probability density function shows the probability of Mednax stock to fall within a particular range of prices over 90 days. Allowing for the 90-day total investment horizon the stock has a beta coefficient of 1.8069. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Mednax will likely underperform. Additionally, mednax Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 10.03HorizonTargetOdds Above 10.03
97.68%90 days
 10.03 
2.28%
Based on a normal probability distribution, the odds of Mednax to move above the current price in 90 days from now is roughly 2.28 (This Mednax Inc probability density function shows the probability of Mednax Stock to fall within a particular range of prices over 90 days) .

Mednax Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Mednax that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mednax's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mednax's value.
InstituionRecorded OnShares
Invenomic Capital Management, Lp2023-12-31
1.4 M
Morgan Stanley - Brokerage Accounts2023-12-31
1.4 M
Boston Partners Global Investors, Inc2023-12-31
1.3 M
Amvescap Plc.2023-12-31
M
Aristotle Capital Boston, Llc2023-12-31
824.5 K
Northern Trust Corp2023-12-31
822.1 K
Bank Of New York Mellon Corp2023-12-31
741.4 K
Citadel Advisors Llc2023-09-30
740.1 K
Arrowmark Colorado Holdings, Llc (arrowmark Partners)2023-12-31
694.2 K
Blackrock Inc2023-12-31
13.6 M
Vanguard Group Inc2023-12-31
10.4 M
View Mednax Diagnostics

Mednax Historical Income Statement

Mednax Inc Income Statement is one of the three primary financial statements used for reporting Mednax's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mednax Inc revenue and expense. Mednax Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Mednax's EBIT is projected to decrease significantly based on the last few years of reporting. The current year's EBITDA is expected to grow to about 288.6 M, whereas Interest Expense is forecasted to decline to about 24.4 M. View More Fundamentals

Mednax Stock Against Markets

Picking the right benchmark for Mednax stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mednax stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mednax is critical whether you are bullish or bearish towards Mednax Inc at a given time. Please also check how Mednax's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Mednax without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Commodity Channel Now

   

Commodity Channel

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Module

Mednax Corporate Directors

Mednax corporate directors refer to members of a Mednax board of directors. The board of directors generally takes responsibility for the Mednax's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Mednax's board members must vote for the resolution. The Mednax board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Enrique SosaIndependent DirectorProfile
Paul GabosIndependent DirectorProfile
Pascal GoldschmidtIndependent DirectorProfile
Donna ShalalaIndependent DirectorProfile

How to buy Mednax Stock?

Before investing in Mednax, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Mednax. To buy Mednax stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Mednax. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Mednax stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Mednax Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Mednax Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Mednax Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Mednax Stock please use our How to Invest in Mednax guide.

Already Invested in Mednax Inc?

The danger of trading Mednax Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mednax is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mednax. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mednax Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Mednax Inc is a strong investment it is important to analyze Mednax's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mednax's future performance. For an informed investment choice regarding Mednax Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.31)
Revenue Per Share
24.265
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0432
Return On Equity
(0.07)
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.